UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 85 filers reported holding UROGEN PHARMA LTD in Q2 2020. The put-call ratio across all filers is 1.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $3,974,000 | -86.0% | 222,776 | -73.8% | 0.97% | -78.4% |
Q4 2019 | $28,347,000 | +35.6% | 849,478 | -3.2% | 4.49% | +47.2% |
Q3 2019 | $20,902,000 | -42.6% | 877,120 | -13.5% | 3.05% | +14.4% |
Q2 2019 | $36,446,000 | -0.0% | 1,014,078 | +2.8% | 2.67% | +16.4% |
Q1 2019 | $36,455,000 | +83.4% | 986,878 | +113.8% | 2.29% | +72.0% |
Q4 2018 | $19,880,000 | +26.8% | 461,678 | +39.1% | 1.33% | +83.7% |
Q3 2018 | $15,676,000 | -5.1% | 331,900 | 0.0% | 0.72% | +31.1% |
Q2 2018 | $16,515,000 | -11.8% | 331,900 | -11.9% | 0.55% | -13.5% |
Q1 2018 | $18,724,000 | +25.8% | 376,823 | -5.8% | 0.64% | +29.9% |
Q4 2017 | $14,880,000 | +15.1% | 399,900 | -2.5% | 0.49% | +34.1% |
Q3 2017 | $12,923,000 | +68.2% | 410,000 | -3.6% | 0.37% | +51.0% |
Q2 2017 | $7,681,000 | – | 425,300 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wildcat Capital Management, LLC | 900,148 | $23,512,000 | 8.12% |
Horton Capital Management, LLC | 383,428 | $10,015,000 | 7.55% |
MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $77,177,000 | 1.89% |
Phoenix Holdings Ltd. | 897,464 | $22,251,000 | 0.94% |
SHIKIAR ASSET MANAGEMENT INC | 51,175 | $1,337,000 | 0.61% |
Migdal Insurance & Financial Holdings Ltd. | 738,302 | $19,284,000 | 0.31% |
Coastal Bridge Advisors, LLC | 37,000 | $966,000 | 0.31% |
Clal Insurance Enterprises Holdings Ltd | 529,388 | $13,828,000 | 0.27% |
ALGERT GLOBAL LLC | 10,880 | $284,000 | 0.10% |
BANK HAPOALIM BM | 14,831 | $387,000 | 0.09% |